U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432347) titled 'Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches' on Feb. 19.
Brief Summary: This is a national, observational, retrospective, cross-sectional, non-profit study focused on patients with HCC. The study aims to characterize the expression and function of novel noncoding regulatory transcripts, including those containing TEsin the microenvironment of liver tumors, with emphasis on their role in T cell dysfunction.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Hepatocarcinoma
Intervention:
GENETIC: Collection of tumor tissue (Fresh or/and archival FFPE), blood samples
NG...